Alliance for Safe Biologic Medicines Welcomes First Steps Towards Patient-Centered Biosimilars Pathway

December 9, 2011

Robust clinical trials will ensure that biosimlars are safe and effective for patients Washington, D.C. – The Alliance for Safe Biologic Medicines (ASBM), a national not-for-profit organization dedicated to ensuring patient safety and access to biologic medicines, welcomes the first steps from the U.S. Food and Drug Administration (FDA) to bring biosimilars on the market […]

Read More